Alan Green talks market crash, scaling in, Shell #RDSB, Open Orphan #ORPH & Eddie Stobart #ESL on Vox Markets podcast
Alan Green discusses the market crash, scaling in, Shell #RDSB, Open Orphan #ORPH & Eddie Stobart #ESL with Justin Waite on the Vox Markets podcast. Interview starts 9 minutes 49 seconds in.
Open Orphan #ORPH – Development of the World’s First Human Coronavirus Challenge Study Model
Open Orphan, the rapidly growing specialist Clinical Research Organisation (“CRO”) pharmaceutical services company whose London-based subsidiary hVIVO is the world leader in the provision of virology and vaccine challenge study services, is pleased to announce that it has commenced the development of the world’s first commercial human coronavirus challenge study model, also known as a Controlled […]
Sunday Times – Coronavirus vaccine race: volunteers to be infected in the UK
Human guinea pigs in a London lab are to be given a form of the killer virus as the search for a lucrative jab hots up It sounds tempting: a payment of £3,500 to spend two weeks relaxing in front of the television, playing video games or catching up on some reading. There is a […]
Open Orphan tip of the year update on mega contract win
by Tom Winnifrith Open Orphan (ORPH) was one of my tips of the year at a 4.6p offer. The shares are now 5.5p bid – the recent market sell off hitting it like nearly all other stocks. But the news today of a contract potentially worth £10 million plus really does slam home the message […]
Irish Times – Open Orphan seals deal that could net more than €11.6m
by Colin Gleeson Dublin-listed pharma group announces contract with European biotech company Dublin-listed pharma services company Open Orphan has announced the signing of a new contract with a European biotech company that could yield it more than £10 million in revenue this year. Open Orphan, a European-focussed, rare and orphan drug consulting services platform, informed the Irish […]
Open Orphan #ORPH – New hVIVO contract signed with a European Biotech Company to provide RSV human challenge study
6 March 2020: Open Orphan plc (ORPH) the rapidly growing CRO specialist pharmaceutical services Group which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services, is pleased to announce the signing of a new contract with a European Biotech Company for the provision of a RSV human […]
Open Orphan #ORPH – Change in Registered Office
Open Orphan , the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services , announces that the Company is moving its registered office and that, with effect from today, the registered office address will change to Queen […]
Alan Green talks Coronavirus and markets, plus Open Orphan #ORPH & Metro Bank #MTRO on the UK Investor Magazine podcast
Alan Green discusses Coronavirus and markets, plus Open Orphan #ORPH & Metro Bank #MTRO with Jonathan Roy on the UK Investor Magazine podcast. Link on the image to listen.
Shares Magazine Spotlight – Open Orphan lining up for coronavirus fight
Open Orphan #ORPH – Appointment of new Director
Open Orphan , the rapidly growing specialist CRO pharmaceutical services company which has a focus on orphan drugs and is a world leader in the provision of virology and vaccine challenge study services , is pleased to announce, further to its announcement of 13 February 2020, the appointment to the board of Leo Toole as Chief Financial […]